The study drug is a potential new treatment for Alzheimer’s disease.
It is hoped that this treatment could alter the course of the disease, rather than temporarily treating its symptoms like most drugs for Alzheimer’s disease do.
There currently are several medications that can affect the course of Alzheimer’s disease butThe trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!